Medfield, MA, United States of America

Niels Borgstein

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 80(Granted Patents)


Company Filing History:


Years Active: 2014-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Niels Borgstein: Innovator in Hematology

Introduction

Niels Borgstein is a notable inventor based in Medfield, MA (US), recognized for his contributions to the field of hematology. With a total of two patents to his name, he has made significant strides in developing methods to enhance red blood cell levels in vertebrates, particularly humans.

Latest Patents

Borgstein's latest patents include "Antagonists of activin-ActRIIa and uses for increasing red blood cell levels." This invention provides compositions and methods aimed at increasing red blood cell and hemoglobin levels in various vertebrates, including rodents and primates, with a specific focus on human applications. The innovative approach outlined in his patents has the potential to address critical health issues related to anemia and other blood-related conditions.

Career Highlights

Niels Borgstein is currently associated with Acceleron Pharma Inc., a company dedicated to developing innovative therapies for serious diseases. His work at Acceleron Pharma has positioned him at the forefront of research in hematology, contributing to advancements that could significantly improve patient outcomes.

Collaborations

Throughout his career, Borgstein has collaborated with esteemed colleagues such as Matthew L. Sherman and Jasbir S. Seehra. These partnerships have fostered a collaborative environment that enhances the research and development of groundbreaking medical solutions.

Conclusion

Niels Borgstein's innovative work in the field of hematology, particularly through his patents and collaborations, underscores his commitment to advancing medical science. His contributions have the potential to make a lasting impact on the treatment of blood-related disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…